Abstract
p53 immunostaining was evaluated in cancerous epithelia and adjacent intestinal metaplasia of 135 gastric cancer specimens. The differential p53 overexpression in different subtypes of intestinal metaplasia and gastric cancer suggests that type III intestinal metaplasia is the commonest lesion in dysplasia-carcinoma transition, particularly in the intestinal type of gastric cancer.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wu, MS., Shun, CT., Lee, WC. et al. Overexpression of p53 in different subtypes of intestinal metaplasia and gastric cancer. Br J Cancer 78, 971–973 (1998). https://doi.org/10.1038/bjc.1998.611
Issue Date:
DOI: https://doi.org/10.1038/bjc.1998.611
This article is cited by
-
Different effects of p53 protein overexpression on the survival of gastric cancer patients according to Lauren histologic classification: a retrospective study
Gastric Cancer (2021)
-
Prognostic Significance of p53 Protein Expression in Early Gastric Cancer
Pathology & Oncology Research (2011)
-
Bio-characteristics of intestinal metaplasia in the stomach: Hyperproliferative and usual type
Chinese Journal of Cancer Research (2006)
-
Three independent genetic profiles based on mucin expression in early differentiated-type gastric cancers—a new concept of genetic carcinogenesis of early differentiated-type adenocarcinomas
Modern Pathology (2004)